Published on
Jan 22, 2025
AI-Designed Drug to Enter Trials by Year-End, Says Google’s Hassabis
As reported by The Financial Times, Sir Demis Hassabis, the founder of Isomorphic Labs, a drug discovery start-up owned by Google’s parent company Alphabet, announced that the company plans to have its first AI-designed drug in clinical trials by the end …
Source:
Sri Lanka Guardian
-
Neutral
